Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
12
×
boston blog main
boston top stories
12
×
deals
12
×
life sciences
national blog main
national top stories
san francisco blog main
clinical trials
san francisco top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
startups
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
eli lilly
investing
novartis
abbvie
alzheimer's disease
amgen
What
drug
12
×
medicines
roundup
bio
disease
cancer
companies
fda
new
acquisitions
approval
biggest
candidate
cash
ceo
company
deal
earlier
gene
hepatitis
nash
news
pharma
pharmaceuticals
pipeline
potential
price
research
roche
team
today
year
acquire
adds
agreed
ahead
albert
alliance
alternative
alzheimer’s
Language
unset
unknown
Current search:
biotech
×
deals
×
drug
×
" boston top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More